Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dental Care | 4 | 2020 | 286 | 0.990 |
Why?
|
Rural Population | 2 | 2020 | 2322 | 0.670 |
Why?
|
Progestins | 1 | 2017 | 302 | 0.500 |
Why?
|
Income | 2 | 2020 | 1878 | 0.470 |
Why?
|
Oral Health | 1 | 2020 | 493 | 0.460 |
Why?
|
Siblings | 1 | 2017 | 829 | 0.430 |
Why?
|
Premature Birth | 3 | 2021 | 1814 | 0.400 |
Why?
|
Drug Utilization | 1 | 2017 | 1191 | 0.380 |
Why?
|
Colon | 1 | 2019 | 1804 | 0.380 |
Why?
|
Colitis, Ulcerative | 2 | 2023 | 1931 | 0.370 |
Why?
|
Insurance, Health | 7 | 2021 | 2518 | 0.340 |
Why?
|
Drug Costs | 1 | 2017 | 1198 | 0.330 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9549 | 0.310 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3047 | 0.310 |
Why?
|
Crohn Disease | 1 | 2019 | 2297 | 0.270 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 810 | 0.250 |
Why?
|
Databases, Factual | 8 | 2021 | 8095 | 0.220 |
Why?
|
Algorithms | 5 | 2022 | 14199 | 0.180 |
Why?
|
Insurance, Dental | 1 | 2021 | 64 | 0.180 |
Why?
|
Medical Record Linkage | 1 | 2021 | 286 | 0.170 |
Why?
|
Insurance Claim Review | 3 | 2021 | 746 | 0.160 |
Why?
|
Pregnancy, Multiple | 1 | 2020 | 216 | 0.160 |
Why?
|
Statistics as Topic | 2 | 2018 | 2359 | 0.160 |
Why?
|
Mouth Diseases | 1 | 2021 | 239 | 0.150 |
Why?
|
Periodontal Diseases | 1 | 2021 | 455 | 0.150 |
Why?
|
United States | 13 | 2022 | 73180 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2023 | 81892 | 0.150 |
Why?
|
Autistic Disorder | 2 | 2020 | 1240 | 0.150 |
Why?
|
Child | 13 | 2022 | 80969 | 0.140 |
Why?
|
Comorbidity | 7 | 2023 | 10591 | 0.140 |
Why?
|
Pigments, Biological | 1 | 2017 | 52 | 0.140 |
Why?
|
Araceae | 1 | 2017 | 18 | 0.140 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2260 | 0.140 |
Why?
|
Electronic Health Records | 4 | 2022 | 4879 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 468 | 0.140 |
Why?
|
Biosynthetic Pathways | 1 | 2017 | 138 | 0.130 |
Why?
|
Neuromuscular Diseases | 1 | 2019 | 261 | 0.130 |
Why?
|
Cell Differentiation | 2 | 2013 | 11684 | 0.130 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2019 | 261 | 0.130 |
Why?
|
Adolescent | 13 | 2022 | 89247 | 0.120 |
Why?
|
Humans | 47 | 2023 | 768887 | 0.120 |
Why?
|
Irritable Bowel Syndrome | 1 | 2021 | 455 | 0.120 |
Why?
|
Bronchiolitis | 1 | 2021 | 492 | 0.120 |
Why?
|
Female | 27 | 2022 | 397464 | 0.120 |
Why?
|
Child, Preschool | 8 | 2022 | 42684 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 559 | 0.120 |
Why?
|
Computational Biology | 3 | 2020 | 3562 | 0.120 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2021 | 843 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1900 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 1014 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 944 | 0.110 |
Why?
|
Odds Ratio | 3 | 2022 | 9682 | 0.110 |
Why?
|
Infant, Newborn | 8 | 2022 | 26394 | 0.110 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 831 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 873 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8745 | 0.100 |
Why?
|
Data Collection | 1 | 2021 | 3322 | 0.100 |
Why?
|
Colonoscopy | 1 | 2019 | 1410 | 0.090 |
Why?
|
Health Expenditures | 2 | 2021 | 2396 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2022 | 2660 | 0.090 |
Why?
|
Natural Language Processing | 1 | 2020 | 1203 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20244 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1042 | 0.090 |
Why?
|
Adult | 14 | 2021 | 223818 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7956 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2012 | 755 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 1001 | 0.080 |
Why?
|
Accidental Falls | 1 | 2017 | 1080 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4265 | 0.080 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 178 | 0.080 |
Why?
|
Medicare Part C | 1 | 2013 | 332 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5323 | 0.080 |
Why?
|
Reimbursement, Incentive | 1 | 2013 | 549 | 0.080 |
Why?
|
Hospitals | 2 | 2021 | 3903 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2022 | 3985 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2965 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6805 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3780 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1765 | 0.070 |
Why?
|
Male | 19 | 2022 | 365249 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3233 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2896 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10641 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13593 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3279 | 0.070 |
Why?
|
Opioid-Related Disorders | 2 | 2018 | 2189 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7860 | 0.060 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3837 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2012 | 1758 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1251 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6213 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8055 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2016 | 3080 | 0.060 |
Why?
|
Infant | 6 | 2022 | 36541 | 0.050 |
Why?
|
Primary Health Care | 1 | 2020 | 4748 | 0.050 |
Why?
|
Schizophrenia | 1 | 2022 | 6987 | 0.050 |
Why?
|
Models, Statistical | 2 | 2017 | 5107 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5520 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2848 | 0.050 |
Why?
|
Pregnancy | 3 | 2021 | 30175 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6888 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11934 | 0.050 |
Why?
|
Protein Folding | 1 | 2006 | 871 | 0.050 |
Why?
|
Biological Factors | 1 | 2023 | 158 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9264 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2013 | 1891 | 0.050 |
Why?
|
Medication Adherence | 1 | 2013 | 2192 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1893 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 2445 | 0.050 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 367 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6346 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
Tremor | 1 | 2021 | 196 | 0.040 |
Why?
|
Aged | 10 | 2022 | 171790 | 0.040 |
Why?
|
Organ Specificity | 2 | 2017 | 1970 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 2957 | 0.040 |
Why?
|
Risk Assessment | 2 | 2021 | 24330 | 0.040 |
Why?
|
Middle Aged | 11 | 2021 | 223740 | 0.040 |
Why?
|
Depression | 1 | 2019 | 8240 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2012 | 10486 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 74971 | 0.040 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2019 | 64 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3253 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7609 | 0.040 |
Why?
|
Cell Line | 1 | 2012 | 15603 | 0.040 |
Why?
|
Prospective Studies | 2 | 2019 | 54950 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12252 | 0.040 |
Why?
|
Private Sector | 1 | 2021 | 396 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2021 | 344 | 0.040 |
Why?
|
Propanols | 1 | 2017 | 9 | 0.040 |
Why?
|
Phenotype | 4 | 2019 | 16735 | 0.040 |
Why?
|
Chlorophyll | 1 | 2017 | 30 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12563 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2021 | 868 | 0.030 |
Why?
|
Hospitalization | 3 | 2022 | 10845 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2019 | 15889 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12093 | 0.030 |
Why?
|
Computer Simulation | 2 | 2021 | 6289 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 630 | 0.030 |
Why?
|
Gait | 1 | 2021 | 822 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 620 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2020 | 503 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 60110 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2017 | 526 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 606 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9524 | 0.030 |
Why?
|
Carotenoids | 1 | 2017 | 620 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2023 | 1597 | 0.030 |
Why?
|
Publishing | 1 | 2021 | 837 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7472 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1397 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15875 | 0.020 |
Why?
|
Forecasting | 1 | 2021 | 2946 | 0.020 |
Why?
|
Birth Weight | 1 | 2020 | 2108 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21545 | 0.020 |
Why?
|
Proteins | 1 | 2006 | 6011 | 0.020 |
Why?
|
Substance-Related Disorders | 2 | 2018 | 4429 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1959 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7245 | 0.020 |
Why?
|
Signal Transduction | 2 | 2016 | 23652 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2357 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22294 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3585 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1968 | 0.020 |
Why?
|
Infant, Premature | 1 | 2020 | 2121 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22390 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4862 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10115 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3345 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8512 | 0.020 |
Why?
|
Globins | 1 | 2009 | 405 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2008 | 183 | 0.020 |
Why?
|
Mice | 2 | 2012 | 82074 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2008 | 254 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 368 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2008 | 617 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1667 | 0.020 |
Why?
|
Animals | 3 | 2013 | 169408 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2604 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2008 | 808 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1752 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40266 | 0.010 |
Why?
|
Cognition | 1 | 2022 | 7080 | 0.010 |
Why?
|
Databases, Protein | 1 | 2006 | 390 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1216 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4755 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59738 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18454 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2179 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13677 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4926 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3811 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26384 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6085 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3775 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18065 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4178 | 0.010 |
Why?
|
Mental Disorders | 1 | 2017 | 6879 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30044 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5404 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41800 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65485 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13427 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30266 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 12809 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19023 | 0.010 |
Why?
|
Software | 1 | 2006 | 4480 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14751 | 0.010 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_